• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

具有轻度核异型性的非黏液性鳞屑样成分在鉴别多原发性肺癌与肺内转移瘤中的意义。

Significance of nonmucinous lepidic component with mild nuclear atypia in the discrimination of multiple primary lung cancers from intrapulmonary metastases.

作者信息

Sun Wei, Liu Yu, Liu Xiang-Yang, Lin Dong-Mei, Lv Ning

机构信息

Department of Pathology, Cancer Institute and Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences Beijing, China.

Department of Etiology and Carcinogensis, Cancer Institute and Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences Beijing, China.

出版信息

Int J Clin Exp Pathol. 2014 Oct 15;7(11):7583-96. eCollection 2014.

PMID:25550795
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4270584/
Abstract

The distinguishing of intrapulmonary metastases from multiple primaries is of great clinical importance. Although comprehensive histological assessment (CHA) was recommended for addressing this problem, the limitations of CHA have been addressed. We hypothesized that a nonmucinous lepidic component with mild nuclear atypia (NLCMA) may be one of the important sign suggesting primary lesions. In this study, we measured the value of NLCMA in distinguishing multiple primaries from intrapulmonary metastases. We retrospectively analyzed a cohort of 54 patients with 116 lesions (70 comparisons). Intrapulmonary metastases and multiple primaries were differentiated on the basis of CHA (Method I) and CHA combined with the assessment of NLCMA (Method II), respectively. Then, the results of two methods were compared with survival analysis. 33 cases were defined as multiple primaries and 21 cases as metastases by Method I, while 41 cases as multiple primaries and 13 cases as metastases by Method II. On univariate analysis, there was a better DFS in patients with a tumor ≤ 3 cm (P=0.012), female gender (P=0.011), highest N0 (P=0.002), absent micropapillary (P=0.013), multiple primaries (P=0.008 by method I, P < 0.001 by method II). A multivariate analysis adjusting for gender, tumor size, micropapillary and multiple primaries/metastases (by methodI and method II, respectively) indicated that multiple primaries (by method II) was an independent predictors for DFS. The presence of NLCMA may indicate that a lesion should be defined as primary in multifocal adenocarcinoma.

摘要

区分肺内转移瘤与多个原发性肿瘤具有重要的临床意义。尽管推荐采用全面组织学评估(CHA)来解决这一问题,但CHA的局限性也已得到关注。我们推测具有轻度核异型性的非黏液性鳞屑样成分(NLCMA)可能是提示原发性病变的重要征象之一。在本研究中,我们评估了NLCMA在区分多个原发性肿瘤与肺内转移瘤方面的价值。我们回顾性分析了一组54例患者的116个病灶(70组对照)。分别根据CHA(方法I)以及CHA联合NLCMA评估(方法II)来区分肺内转移瘤和多个原发性肿瘤。然后,通过生存分析比较两种方法的结果。方法I将33例定义为多个原发性肿瘤,21例定义为转移瘤;而方法II将41例定义为多个原发性肿瘤,13例定义为转移瘤。单因素分析显示,肿瘤≤3 cm(P = 0.012)、女性(P = 0.011)、最高N0(P = 0.002)、无微乳头结构(P = 0.013)、多个原发性肿瘤(方法I中P = 0.008,方法II中P < 0.001)的患者无病生存期更好。多因素分析对性别、肿瘤大小、微乳头结构以及多个原发性肿瘤/转移瘤(分别采用方法I和方法II)进行校正后表明,多个原发性肿瘤(采用方法II)是无病生存期的独立预测因素。NLCMA的存在可能表明在多灶性腺癌中一个病灶应被定义为原发性。

相似文献

1
Significance of nonmucinous lepidic component with mild nuclear atypia in the discrimination of multiple primary lung cancers from intrapulmonary metastases.具有轻度核异型性的非黏液性鳞屑样成分在鉴别多原发性肺癌与肺内转移瘤中的意义。
Int J Clin Exp Pathol. 2014 Oct 15;7(11):7583-96. eCollection 2014.
2
Clonality assessment of multifocal lung adenocarcinoma by pathology evaluation and molecular analysis.通过病理评估和分子分析评估多灶性肺腺癌的克隆性。
Hum Pathol. 2018 Nov;81:261-271. doi: 10.1016/j.humpath.2018.01.030. Epub 2018 Jul 3.
3
Histologic lung cancer subtype differentiates synchronous multiple primary lung adenocarcinomas from intrapulmonary metastases.组织学肺癌亚型可区分同步性多发原发性肺腺癌与肺内转移瘤。
J Surg Res. 2017 May 1;211:215-222. doi: 10.1016/j.jss.2016.11.050. Epub 2016 Dec 7.
4
Correlation of histological components with tumor invasion in pulmonary adenocarcinoma.肺腺癌组织学成分与肿瘤侵袭的相关性
World J Surg Oncol. 2014 Dec 17;12:388. doi: 10.1186/1477-7819-12-388.
5
A multidisciplinary approach for the differential diagnosis between multiple primary lung adenocarcinomas and intrapulmonary metastases.多学科方法在多原发肺腺癌与肺内转移瘤鉴别诊断中的应用。
Pathol Res Pract. 2021 Apr;220:153387. doi: 10.1016/j.prp.2021.153387. Epub 2021 Feb 17.
6
Excellent survival in a subgroup of patients with intrapulmonary metastasis of lung cancer.肺癌肺内转移患者亚组中的良好生存率。
Ann Thorac Surg. 1996 Jan;61(1):158-62; discussion 162-3. doi: 10.1016/0003-4975(95)00705-9.
7
[Prognostic significance of intrapulmonary metastases in cases of surgically treated lung cancer].[手术治疗肺癌患者肺内转移的预后意义]
Magy Onkol. 2003;47(4):397-401. Epub 2004 Jan 11.
8
Histological progression of small intrapulmonary metastatic tumor from primary lung adenocarcinoma.肺原发性腺癌肺内小转移瘤的组织学进展。
Pathol Int. 2010 Dec;60(12):765-73. doi: 10.1111/j.1440-1827.2010.02596.x. Epub 2010 Sep 14.
9
[Assessment of prognosis and p 53 mutations in patients with multiple tumors of the lung; intrapulmonary metastasis or double primary cancers?].[肺多发肿瘤患者的预后评估及p53突变;肺内转移还是双原发癌?]
Kyobu Geka. 2002 Jan;55(1):25-9.
10
Discrimination of multiple primary lung cancers from intrapulmonary metastasis based on the expression of four cancer-related proteins.基于四种癌症相关蛋白的表达鉴别多原发性肺癌与肺内转移瘤。
Cancer. 2009 Aug 1;115(15):3489-500. doi: 10.1002/cncr.24382.

引用本文的文献

1
A novel NGS-based diagnostic algorithm for classifying multifocal lung adenocarcinomas in pN0M0 patients.一种基于新一代测序的新型诊断算法,用于对 pN0M0 患者的多灶性肺腺癌进行分类。
J Pathol Clin Res. 2023 Mar;9(2):108-120. doi: 10.1002/cjp2.306. Epub 2022 Dec 29.
2
Differential Diagnostic Value of Histology in MPLC and IPM: A Systematic Review and Meta-Analysis.组织学在多原发性肺癌和原位癌中的鉴别诊断价值:一项系统评价与Meta分析
Front Oncol. 2022 Apr 29;12:871827. doi: 10.3389/fonc.2022.871827. eCollection 2022.
3
[Research Progress in Distinguishing Methods of Simultaneous Multiple Primary Lung Cancer and Intrapulmonary Metastasis].[同时性多原发性肺癌与肺内转移鉴别方法的研究进展]
Zhongguo Fei Ai Za Zhi. 2021 May 20;24(5):365-371. doi: 10.3779/j.issn.1009-3419.2021.101.12.
4
Morphological and genetic heterogeneity of synchronous multifocal lung adenocarcinoma in a Chinese cohort.中国人群中同步多灶性肺腺癌的形态学和遗传学异质性。
BMC Cancer. 2021 Feb 18;21(1):176. doi: 10.1186/s12885-021-07892-8.
5
Multiple Primary Lung Cancers: A New Challenge in the Era of Precision Medicine.多原发性肺癌:精准医学时代的新挑战
Cancer Manag Res. 2020 Oct 20;12:10361-10374. doi: 10.2147/CMAR.S268081. eCollection 2020.

本文引用的文献

1
Micropapillary and solid subtypes of invasive lung adenocarcinoma: clinical predictors of histopathology and outcome.微乳头型和实体型浸润性肺腺癌:组织病理学和预后的临床预测因子。
J Thorac Cardiovasc Surg. 2014 Mar;147(3):921-928.e2. doi: 10.1016/j.jtcvs.2013.09.045. Epub 2013 Nov 4.
2
A dominant adenocarcinoma with multifocal ground glass lesions does not behave as advanced disease.具有多灶磨玻璃样病变的优势性腺癌并不表现为晚期疾病。
Ann Thorac Surg. 2013 Aug;96(2):411-8. doi: 10.1016/j.athoracsur.2013.04.048. Epub 2013 Jun 24.
3
Lesions in patients with multifocal adenocarcinoma are more frequently in the right upper lobes.多灶性腺癌患者的病灶更常见于右上叶。
Interact Cardiovasc Thorac Surg. 2012 Oct;15(4):627-32. doi: 10.1093/icvts/ivs276. Epub 2012 Jun 24.
4
Pulmonary oligometastases: histological features and difficulties in determining site of origin.肺寡转移瘤:组织学特征及确定原发部位的困难
Int J Surg Pathol. 2012 Dec;20(6):577-88. doi: 10.1177/1066896912449039. Epub 2012 Jun 6.
5
Clonality of multifocal nonsmall cell lung cancer: implications for staging and therapy.多灶性非小细胞肺癌的克隆性:对分期和治疗的影响。
Eur Respir J. 2012 Jun;39(6):1437-42. doi: 10.1183/09031936.00105911. Epub 2011 Nov 10.
6
Do all lung adenocarcinomas follow a stepwise progression?所有肺腺癌都遵循逐步进展的模式吗?
Lung Cancer. 2011 Oct;74(1):7-11. doi: 10.1016/j.lungcan.2011.05.021. Epub 2011 Jun 25.
7
International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma.国际肺癌研究协会/美国胸科学会/欧洲呼吸学会国际多学科肺腺癌分类。
J Thorac Oncol. 2011 Feb;6(2):244-85. doi: 10.1097/JTO.0b013e318206a221.
8
Treatment outcomes for patients with synchronous multiple primary non-small cell lung cancer.同步多原发性非小细胞肺癌患者的治疗结果。
Lung Cancer. 2011 Aug;73(2):237-42. doi: 10.1016/j.lungcan.2010.11.008. Epub 2010 Dec 9.
9
Histological progression of small intrapulmonary metastatic tumor from primary lung adenocarcinoma.肺原发性腺癌肺内小转移瘤的组织学进展。
Pathol Int. 2010 Dec;60(12):765-73. doi: 10.1111/j.1440-1827.2010.02596.x. Epub 2010 Sep 14.
10
Frequency of EGFR and KRAS mutations in Japanese patients with lung adenocarcinoma with features of the mucinous subtype of bronchioloalveolar carcinoma.肺腺癌黏液型细支气管肺泡癌特征的日本患者中 EGFR 和 KRAS 突变的频率。
J Thorac Oncol. 2010 Aug;5(8):1197-200. doi: 10.1097/JTO.0b013e3181e2a2bc.